Home / Letter From The Editor / Feb. 16, 2019

Feb. 16, 2019

Feb 16, 2019

I have a good friend who recently left her position as head of a kidney and liver transplant center on the west coast of Florida. She had been an ADN at a large hospital and when they decided to open a transplant center, she was tasked with the responsibility of designing, building and staffing the facility. The facility was up and running on time and they were taking patients on a regular basis. However, as time went by, her frustrations with the availability of good kidneys grew.

You may not know but there is a long process and a longer waiting list to get a new kidney or liver, and just because there is one available in your area does not mean your patient will get it. Part of the problem is the lack of healthy donors. Potential donors are eliminated for many reasons, and a kidney from a person with diabetes is never used for a transplant. This makes sense because diabetes is a major cause of kidney failure, and with the increase in the incidence of diabetes the rates of kidney failure are bound to increase.


This week our LECOM Pharm.D candidate, Annahita Forghan, has prepared two articles on the value of monitoring and correcting albumin to creatinine ratios to reduce end stage kidney risk, and the logic behind that idea.


We can make a difference!


Dave Joffe